MEDICATION
- Adults:
- Piperacillin/tazobactam 3.375 g IV
OR
- Cefotetan: 2 g IV + gentamicin 2 mg/kg IV
OR
- Cefoxitin: 2 g IV + gentamicin 2 mg/kg IV
OR
- Ceftriaxone: 1–2 g IV + Flagyl 15 mg/kg IV
OR
- Clindamycin: 600 mg IV + gentamicin 2 mg/kg IV
- Children:
- Cefotetan: 20 mg/kg IV + gentamicin 2 mg/kg IV
OR
- Cefoxitin: 40 mg/kg IV + gentamicin 2 mg/kg IV
OR
- Ceftriaxone: 50 mg/kg per dose IV + Flagyl 15 mg/kg IV
First Line
Ceftriaxone and Flagyl or piperacillin/tazobactam or carbapenem:
- Goal is to choose broad-spectrum coverage with both aerobic and anaerobic coverage, particularly of enteric gram-negative organisms.
Second Line
Addition of an aminoglycoside, as it has good activity in an alkaline environment:
- Particularly useful if patient is unstable for broader gram-negative coverage
Adjunct Therapy
There is no good evidence to support the use of octreotide as studies still conflict on the benefits and adverse effects.
FOLLOW-UP
DISPOSITION
Admission Criteria
- All patients with suspected pancreatic injuries must be admitted.
- Abdominal pain after blunt trauma requires serial exam and observation for 24–72 hr.
- Intoxicated trauma patient requires admission and serial exams for unidentified injury.
Discharge Criteria
Only for very minor trauma and with no evidence of pancreatic or any other intra-abdominal injury with appropriate follow-up and return precautions
Issues for Referral
- Patient with surgical drains or complications such as fistula formation may need further surgical, GI, and wound care evaluations.
- Most patients need close monitoring and follow-up within 1 wk.
FOLLOW-UP RECOMMENDATIONS
Delayed presentation of pancreatic injury is rare, but complications may arise and should be considered:
- Pancreatitis, pseudocysts, vascular aneurysms (such as splenic artery)
- Rare for exocrine or endocrine dysfunction to occur unless a majority of the pancreas is resected/destroyed:
- Evaluate for glucose intolerance and digestive abnormalities
PEARLS AND PITFALLS
- Always consider pancreatic injury when evaluating abdominal or back trauma, both blunt and penetrating.
- Beware of nearby vascular injuries.
- Assess for related injuries.
- Choose the best imaging modality and obtain as rapidly as possible.
- Penetrating trauma or unstable patients should be rapidly prepared for surgical exploration.
ADDITIONAL READING
- Ahmed N, Vernick JJ. Pancreatic injury.
South Med J
. 2009;102(12):1253–1256.
- Almaramhy HH, Guraya SY. Computed tomography for pancreatic injuries in pediatric blunt abdominal trauma.
World J Gastrointest Surg
. 2012;4(7):166–170.
- Beckingham IJ, Krige JE. ABC of diseases of liver, pancreas and biliary system: Liver and pancreatic trauma.
BMJ
. 2001;322:783–785.
- Rekhi S, Anderson SW, Rhea JT, et al. Imaging of blunt pancreatic trauma.
Emerg Radiol
. 2010;17(1):13–19.
- Vasquez JC, Coimbra R, Hoyt DB, et al. Management of penetrating pancreatic trauma: An 11-year experience of a level-1 trauma center.
Injury
. 2001;32(10):753–759.
- Wolf A, Bernhardt J, Patrzyk M, et al. The value of endoscopic diagnosis and the treatment of pancreas injuries following blunt abdominal trauma.
Surg Endosc
. 2005;19(5):665–669.
CODES
ICD9
- 863.84 Injury to pancreas, multiple and unspecified sites, without mention of open wound into cavity
- 863.94 Injury to pancreas, multiple and unspecified sites, with open wound into cavity
ICD10
- S36.209A Unspecified injury of unspecified part of pancreas, initial encounter
- S36.229A Contusion of unspecified part of pancreas, initial encounter
- S36.239A Laceration of unspecified part of pancreas, unspecified degree, initial encounter
PANCREATITIS
Trevor Lewis
BASICS
DESCRIPTION
- Inflammation of pancreas due to activation, interstitial liberation, and digestion of gland by its ownenzymes
- Acute pancreatitis:
- Exocrine and endocrine function of gland impaired for weeks to months
- Glandular function will return to normal.
- Chronic pancreatitis:
- Exocrine and endocrine function progressively deteriorates with resultant steatorrhea and malabsorption.
- Dysfunction progressive and irreversible
- Pancreatic pseudocyst:
- Cystic collection of fluid with high content of pancreatic enzymes surrounded by a wall of fibrous tissue lacking a true epithelial lining
- Localized in parenchyma of pancreas or adjacent abdominal spaces (lesser peritoneal sac)
- Requires 4–6 wk to form from onset of acute pancreatitis
ETIOLOGY
- Gallstones and alcohol abuse most common causes of
acute pancreatitis
(75–80%)
- Alcohol abuse accounts for 70–80% of
chronic pancreatitis.
- Acute:
- Biliary tract disease
- Chronic alcoholism
- Obstruction of pancreatic duct
- Ischemia
- Medications
- Infectious
- Postoperative
- Post-ERCP
- Metabolic diseases
- Trauma
- Scorpion venom
- Penetrating peptic ulcer
- Hereditary
- Chronic:
- Chronic alcoholism
- Obstruction pancreatic duct
- Tropical
- Hereditary
- Shwachman disease
- Enzyme deficiency
- Idiopathic
- Hyperlipedemia
- Hypercalcemia
- Pancreatic pseudocyst:
- Complication in 5–16% of acute pancreatitis; 20–40% of chronic pancreatitis
Pediatric Considerations
Causes mainly viral, trauma, and medications
DIAGNOSIS
SIGNS AND SYMPTOMS
- Frequency:
- Abdominal pain: 95–100%
- Epigastric tenderness: 95–100%
- Nausea and vomiting: 70–90%
- Low-grade fever: 70–85%
- Hypotension: 20–40%
- Jaundice: 30%
- Grey Turner/Cullen sign: <5%
- Subcutaneous or SQ
- GI:
- Severe, persistent epigastric pain radiating to back:
- Colicky or rebound tenderness suggests nonpancreatic source.
- Worse when supine
- Nausea, vomiting, and anorexia
- Bowel sounds usually decreased or absent
- Significant GI bleed in patients with acute severe pancreatitis is uncommon.
- Cullen sign:
- Bluish discoloration at umbilicus secondary to hemorrhagic pancreatitis
- Grey Turner sign:
- Bluish discoloration at flank secondary to hemorrhagic pancreatitis
- Respiratory:
- Pleuritic chest pain
- Dyspnea
- Lung exam:
- Left pleural effusion (most common)
- Atelectasis
- Pulmonary edema
- Hypoxemia (30%)
- Cardiac:
- Tachycardia
- Hypotension
- Shock
- Neurologic:
- Irritability
- Confusion
- Coma
- Chvostek and Trousseau signs are rare despite lab evidence of hypocalcemia.
Ranson Criteria
- Indicators of morbidity and mortality:
- 0–2 criteria: 2% mortality
- 3 or 4 criteria: 15% mortality
- 5 or 6 criteria: 40% mortality
- 7 or 8 criteria: 100% mortality
- Criteria on admission:
- Age >55 yr
- WBC count >16,000 mm
3
- Blood glucose >200 mg/dL
- Serum lactate dehydrogenase >350 IU/L
- AST >250 IU/L
- Criteria during 1st 48 hr:
- Hematocrit fall >10%
- BUN increase >5 mg/dL
- Serum calcium <8 mg/dL
- Arterial PO
2
<60 mm Hg
- Base deficit >4 mEq/L
- Estimated fluid sequestration >6 L
ESSENTIAL WORKUP
Lab tests to confirm physical diagnosis